Market revenue in 2023 | USD 753.3 million |
Market revenue in 2030 | USD 1,019.3 million |
Growth rate | 4.4% (CAGR from 2023 to 2030) |
Largest segment | Cmos & cdmos |
Fastest growing segment | CMOs & CDMOS |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biopharmaceutical Companies, CMOs & CDMOS, Academic And Research Organizations |
Key market players worldwide | Danone SA, Roche Holding AG ADR, Koninklijke DSM NV, Lonza Group Ltd, Novonesis AS ADR, Biocon, BioVectra, TerraVia - Assets, BiOZEEN |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microbial fermentation technology market will help companies and investors design strategic landscapes.
Cmos & cdmos was the largest segment with a revenue share of 41.91% in 2023. Horizon Databook has segmented the France microbial fermentation technology market based on biopharmaceutical companies, cmos & cdmos, academic and research organizations covering the revenue growth of each sub-segment from 2018 to 2030.
The number of biopharmaceutical companies in France has significantly increased over the past few decades. French biopharmaceutical players such as Sanofi, Servier, Pierre Fabre, and Ipsen are focused on the development of novel therapies. Such developments are expected to significantly boost the demand for microbial fermentation technology in the country during the forecast period.
Furthermore, expansion of an existing facility along with the construction of new facilities for biomanufacturing is expected to enhance the implementation of microbial fermentation technology. For instance, in March 2022, Catalent Biologics announced the opening of a new facility in Limoges for the manufacturing of drug products, fill-finish stages, and biopharmaceutical development with a USD 30 million investment.
Horizon Databook provides a detailed overview of country-level data and insights on the France microbial fermentation technology market , including forecasts for subscribers. This country databook contains high-level insights into France microbial fermentation technology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account